Ocata Therapeutics Inc fka OCAT

[rocky301]

elk,


When I read the PR from Roslin on the agreement, I came away with the following.
http://www.roslincells.com/sitepix/downloads/RC%20Pfizer%20PSC%20Line%20Evaluation_13Jul11.pdf

First, Pfizer is no stranger to the UK, they have many things going on there. Roslin Cell is proving itself to be a leader in this process and is even taking steps towards standardization which will be paramount going forward, imo, so Pfizers interest is warranted.

The agreement is for Roslin's Cell lines which are already being used in research programs. They also state in PR "Commercial terms are confidential and not disclosed."

The ACT lines will have to be processed and verified by Roslin as stated here, which will take some time.
http://www.roslincells.com/quality_control.asp

In summary, ACT will be involved with any commercialization of single blastomere lines. While Pfizer may show interest when they are available, this PR, at least for now is all Roslin/Pfizer..imo